SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-20-005220
Filing Date
2020-03-10
Accepted
2020-03-10 10:13:36
Documents
2
Group Members
CITIGROUP FINANCIAL PRODUCTS INC.CITIGROUP GLOBAL MARKETS HOLDINGS INC.CITIGROUP GLOBAL MARKETS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A formsc13ga.htm SC 13G/A 136147
2 EXHIBIT 1 ex99_1.htm EX-99.1 10366
  Complete submission text file 0001140361-20-005220.txt   148492
Mailing Address 388 GREENWICH STREET NEW YORK NY 10013
Business Address 388 GREENWICH STREET NEW YORK NY 10013 2125591000
CITIGROUP INC (Filed by) CIK: 0000831001 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Subject) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90534 | Film No.: 20700265
SIC: 2834 Pharmaceutical Preparations